The burgeoning popularity of retatrutide, initially for blood sugar control , is creating significant attention within the UK , prompting a notable shift in hormone trends. Obtaining these medications remains a complex situation , with public healthcare system coverage currently limited and specialist practices offering therapy at a premium . Worri